I have already reported it here and the recruitment of children is still going on and will end in December 2011:
|Sponsor:||Eli Lilly and Company|
|Information provided by:||Eli Lilly and Company|
The purpose of this study is to assess whether duloxetine is superior to placebo in the treatment of children and adolescents with major depressive disorder (MDD)
|Major Depressive Disorder||Drug: Placebo|
|Study Design:||Allocation: Randomized|
Control: Placebo Control
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder|
|Ages Eligible for Study:||7 Years to 17 Years|
|Genders Eligible for Study:||Both|
|Accepts Healthy Volunteers:||No|
Read more at clinicaltrialsOrg.
"Children (18 years or younger) taking antidepressants experience suicidal thoughts or actions in about 1 out of every 50 who are depressed. Although duloxetine is prescribed for children, the FDA has not approved duloxetine for use in children."
Still this study is being done since last year. After reading the post below it seems that neither Japanese or American children are respected and when profit is being done at the expenses of the health and life of children it is hard to understand what is integrity and ethics in medicine.